President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Sam Stovall, Chief Investment Strategist at CFRA Research, joins Cheddar News' Closing Bell where he dives into the factors contributing to Monday's market plunge and what could be in store when February's CPI data comes out on Tuesday.
Derek Shearer, former U.S. Ambassador to Finland and contributing writer for Washington Monthly, joins Cheddar News to discuss the latest developments in the Russia-Ukraine conflict.
Americans continue to feel the pain at the pump as a result of Russia’s invasion of Ukraine. Patrick DeHaan, head of petroleum analysis at GasBuddy, joined Cheddar News to discuss how prices are being affected by the war and how much worse it could potentially get for drivers. "It's obviously a fluid situation. In one field today, I might feel differently in a half hour. But for now, I think we could see the national average realistically go somewhere into the mid $4 range, maybe $4.40 to $4.65 based on what we're seeing," he said.
Russia’s invasion of Ukraine has entered its 12th day following what Ukrainian authorities described as increased shelling of encircled cities and another failed attempt to evacuate civilians from the port city of Mariupol.
Gasoline prices are pushing even farther above $4 a gallon, the highest price that American motorists have faced since July 2008, as calls grow to ban imports of Russian oil.
Jay Hatfield, Chief Investment Officer at ICAP, believes a lot of the bad news regarding the fighting in Ukraine and Fed is already priced into the market and looming uncertainty factored into Friday's movement. However, he also believes the upcoming Fed decision will be good news for Wall Street.
News of Russian forces taking control of a Ukrainian after artillery bombardment of a nuclear power plant raised concerns this week. Nuclear policy expert and Quincy Institute Distinguished Fellow Joe Cirincione joined Cheddar News to discuss the implications for a potential disaster. “I’m with the director general of the IAEA, the International Atomic Energy Agency. He says that he is extremely concerned, and that this Russian attack is a severe risk and that Russia clearly violated the fundamental principle of preserving the integrity of nuclear power plants," Cirincione said.
Amid Russia's attack on Ukraine, major businesses from BP to Big Tech like Apple have been pausing their business dealings with the invading nation. Brian Walker, chief strategy officer at commerce software company Bloomreach, joined Cheddar News to discuss how some companies are showing support for Ukraine and what this could mean for consumers. "Whether it be impacts on energy or operational costs, shipping and logistics, or frankly impacts on the financial services industry, these will have long term implications on retail prices," he said.
